• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对多种铂衍生物耐药的L1210细胞亚系的生长、流式细胞术及染色体特征分析

Growth, flow cytometric, and karyological characterization of L1210 cell sublines resistant to various Pt derivatives.

作者信息

Hrubisko M, Kysela B, Kuliffay P

机构信息

Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Czechoslovakia.

出版信息

Neoplasma. 1989;36(4):401-10.

PMID:2770927
Abstract

Growth, flow cytometric, and karyological characteristics were analyzed with respect to differences between sensitive L1210 cells and eight sublines resistant to cisplatin (DDP), 1,2-diaminocyclohexane(DACH)-Pt(II) citrate, DACH-Pt(II) glucarate, cis-dichloro-bis-(isopropylamine)-trans-dihydroxyplatinum (IV) (CHIP, iproplatin), and methotrexate (MTX). No great differences were found in growth properties. The sensitive and a majority of resistant sublines displayed similar flow cytometric and karyological characteristics, major differences were found only in the sublines resistant to CHIP. The relationship between the mechanism(s) of resistance and different pharmacokinetics of the drugs is discussed with special reference to DNA content and chromosome structure.

摘要

针对敏感的L1210细胞与八个对顺铂(DDP)、柠檬酸1,2 - 二氨基环己烷(DACH)-Pt(II)、葡糖二酸DACH - Pt(II)、顺 - 二氯 - 双 -(异丙胺)-反 - 二羟基铂(IV)(CHIP,异丙铂)和甲氨蝶呤(MTX)耐药的亚系之间的差异,分析了生长、流式细胞术和染色体学特征。在生长特性方面未发现显著差异。敏感细胞系和大多数耐药亚系表现出相似的流式细胞术和染色体学特征,仅在对CHIP耐药的亚系中发现了主要差异。结合DNA含量和染色体结构,特别讨论了耐药机制与药物不同药代动力学之间的关系。

相似文献

1
Growth, flow cytometric, and karyological characterization of L1210 cell sublines resistant to various Pt derivatives.对多种铂衍生物耐药的L1210细胞亚系的生长、流式细胞术及染色体特征分析
Neoplasma. 1989;36(4):401-10.
2
Role of carrier ligand in platinum resistance in L1210 cells.载体配体在L1210细胞铂耐药中的作用。
Cancer Res. 1990 Oct 15;50(20):6497-501.
3
Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.轴向和赤道配体对反式-1R,2R-二氨基环己烷铂(IV)配合物抗肿瘤活性的调节作用。
Anticancer Drug Des. 1994 Apr;9(2):139-51.
4
Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.铂-抗坏血酸配合物的抗肿瘤活性及交叉耐药性研究。
Neoplasma. 1989;36(6):651-7.
5
Drug resistance induction and cross-resistance studies with Pt-complexes.
Neoplasma. 1984;31(6):649-53.
6
Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.新型反式铂配合物:对铂敏感和耐药小鼠肿瘤的体外和体内活性比较
Anticancer Res. 1996 Jan-Feb;16(1):33-8.
7
Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP).对顺铂和异丙铂(CHIP)单耐药及双耐药的L1210白血病亚系进行交叉耐药研究。
Neoplasma. 1990;37(6):631-8.
8
Comparison of the effectivity of two diaminocyclohexane Pt-complexes.
Neoplasma. 1985;32(5):537-42.
9
Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.轴向和赤道配体介导的1,2-二氨基环己烷铂(IV)配合物的细胞毒性和细胞药理学调节
Cancer Res. 1993 Oct 1;53(19):4567-72.
10
Role of carrier ligand in platinum resistance of human carcinoma cell lines.载体配体在人癌细胞系铂耐药中的作用。
Cancer Res. 1993 Feb 15;53(4):799-805.